021-51111890
购物车（）
sales@molnova.cn
ADT-007
CAS No. 1945941-09-2
ADT-007 ( —— )
产品货号. M37557 CAS No. 1945941-09-2
ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥777 | 有现货 |
|
| 10MG | ￥1169 | 有现货 |
|
| 25MG | ￥2288 | 有现货 |
|
| 50MG | ￥3432 | 有现货 |
|
| 100MG | ￥4734 | 有现货 |
|
| 200MG | ￥6471 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥839 | 有现货 |
|
生物学信息
-
产品名称ADT-007
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
-
产品描述ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
-
体外实验——
-
体内实验——
-
同义词——
-
通路MAPK/ERK Signaling
-
靶点Ras
-
受体Ras
-
研究领域——
-
适应症——
化学信息
-
CAS Number1945941-09-2
-
分子量449.47
-
分子式C26H24FNO5
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(=C/1\C=2C(C(CC(NCC3=CC=CO3)=O)=C1C)=CC(F)=CC2)\C4=CC(OC)=C(O)C(OC)=C4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
ARS-853
ARS-853 是 KRAS(G12C) 突变体特异性共价抑制剂； KRASG12C 参与生化测定，速率常数为 76 M-1s-1。
-
KRAS inhibitor C6ME
KRAS 抑制剂 C6ME 是一种小分子化合物，可在体外阻断 KRASG12V 的生化和细胞功能。
-
KRAS inhibitor-9
KRAS抑制剂-9是一种有效的KRAS抑制剂，Kd为92 μM，可阻断GTP-KRAS的形成和KRAS下游的激活。
